New York State Common Retirement Fund’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,231
| Closed | -$3.03M | – | 3468 |
|
|
2023
Q1 | $3.03M | Sell |
28,231
-8,762
| -24% | -$940K | ﹤0.01% | 1368 |
|
|
2022
Q4 | $4.07M | Sell |
36,993
-5,790
| -14% | -$637K | 0.01% | 1272 |
|
|
2022
Q3 | $2.53M | Buy |
42,783
+5,622
| +15% | +$332K | ﹤0.01% | 1488 |
|
|
2022
Q2 | $1.05M | Buy |
37,161
+4,973
| +15% | +$140K | ﹤0.01% | 1990 |
|
|
2022
Q1 | $1.22M | Buy |
32,188
+14,489
| +82% | +$547K | ﹤0.01% | 2006 |
|
|
2021
Q4 | $700K | Buy |
17,699
+7,882
| +80% | +$312K | ﹤0.01% | 2261 |
|
|
2021
Q3 | $233K | Buy |
9,817
+117
| +1% | +$2.78K | ﹤0.01% | 2859 |
|
|
2021
Q2 | $238K | Buy |
+9,700
| New | +$238K | ﹤0.01% | 2972 |
|